Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice.

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Dopamine delivery to the brain is crucial for cognitive functions.
• Strategies like L-Dopa precursors and galactosylated dopamine (GAL-DA) are explored for brain dopamine delivery.
• Attention deficit hyperactivity disorder (ADHD) is characterized by hyperactivity and attention deficits.

Purpose of the Study:

• To investigate the efficacy of GAL-DA in reducing hyperactivity and enhancing non-selective attention (NSA) in a mouse model of ADHD (C57BL/6 mice).
• To compare the effects of GAL-DA with a galactose vehicle control.
• To assess the impact of different GAL-DA doses on behavior.

Main Methods:

• C57BL/6 mice received a single intraperitoneal injection of GAL-DA (10 mg/kg or 100 mg/kg) or galactose vehicle.
• Swiss albino mice served as an inbred control group.
• Mice were tested in a Làt-maze for 30 minutes, 3 hours post-injection, with behavioral analysis of horizontal and vertical activity.

Main Results:

• A low dose of GAL-DA (10 mg/kg) significantly increased scanning duration in C57BL/6 mice.
• This increase in scanning duration suggests enhanced NSA.
• GAL-DA did not reduce hyperactivity at the tested doses in this ADHD mouse model.

Conclusions:

• GAL-DA can increase non-selective attention in C57BL/6 mice, a model relevant to ADHD.
• Low-dose GAL-DA shows potential for improving attention without exacerbating hyperactivity.
• Further research into GAL-DA as a therapeutic strategy for ADHD is warranted.